Canada Markets open in 5 hrs 9 mins

COMPASS Pathways plc (CMPS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
33.36+0.81 (+2.49%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close32.55
Open32.64
Bid0.00 x 1000
Ask0.00 x 800
Day's Range32.26 - 33.52
52 Week Range22.51 - 61.69
Volume256,291
Avg. Volume385,393
Market Cap1.368B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.70
Earnings DateMay 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est72.11
  • Simply Wall St.

    We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely

    Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

  • GlobeNewswire

    COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs

    COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it has acquired an intellectual property (IP) portfolio including patent applications covering a variety of psychedelic and empathogenic substances. The IP was developed together with inventor Matthias Grill PhD, founder and CEO of MiHKAL GmbH in Basel, Switzerland, who will be working with COMPASS on an exclusive res

  • GlobeNewswire

    Hamilton Morris joins COMPASS Pathways to research new psychedelic compounds

    COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has engaged Hamilton Morris, the research scientist and film-maker, as a full-time consultant, who will be working primarily at the COMPASS Discovery Center, based at University of the Sciences in Philadelphia (USciences) in the United States. Mr Morris will be advising COMPASS on research related to new psychedelic compounds that c